EE518 An Updated Cost-Effectiveness Analysis of Axicabtagene Ciloleucel in Second-Line Large B-Cell Lymphoma Patients in the United States
Oluwole, O., Patel, A., Vadgama, S., Smith, N., Blissett, R.S., Feng, C., Dickinson, M., Johnston, P., Perales, M.A.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article